$INM #null InMed Pharmaceuticals, Inc. (INM: null) | InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Copyright 2020 – OTC Markets Group Inc.

News Link